solid start ast drive upsid
reiter market outperform rate rais price
target follow morn releas result
new price target base previous new
ep estim previous
typic put take segment perform start
fiscal year posit note post upsid top bottom
line maintain annual guidanc sale ep continu believ
compani constant currenc organ sale growth expect along
double-digit earn growth offer attract profil mid-cap compani
med-tech space target impli anoth solid
year board author dividend
total sale came mln y/i rpt cc organ
posit contribut volum price bp consensu
mln appli steril ast continu lead way
increas demand segment medic devic custom
adjust ep quarter grew y/i ahead street
expect albeit sizabl boost lower tax
manag reiter organ growth guidanc y/i
expect lower fx benefit mln previous expect mln adjust ep
guidanc remain rang reflect expect tax rate
unchang despit post quarter
free cash flow quarter mln driven improv
work capit time capit spend increas net incom
previous manag discuss expect free cash flow
approxim mln y/i capital-expenditure mln balanc
sheet cash sit mln long-term debt bln
healthcar product sale mln y/i rpt cc organ versu
consensu mln capit equip increas
servic declin consum limit divestitur
pro forma basi consum grew compani continu expect mid-
single-digit growth capit equip believ segment underli
fundament still stabl oper incom segment came
mln y/i due higher spend neg currenc
neg impact divestitur
thomson reuter jmp secur llc
compani report jmp secur llc
report read conjunct import disclosur inform includ attest regul analyst certif
healthcar specialti servic revenu mln y/i report cc
organ consensu mln oper incom mln
mln prior-year period primarili due continu invest within im north
ast sale mln y/i report cc organ versu consensu
mln driven primarili increas volum core medic devic custom oper incom
mln all-tim record vs mln prior-year period increas
driven larg revenu growth fx chang
life scienc revenu mln y/i report cc organ versu consensu
mln servic sale grew capit equip increas consum sale
oper incom increas mln mln prior-year
period driven larg increas volum
manag offer reiter guidanc call cc top-lin growth ep
rang y/i midpoint street consensu sat midpoint
rang head releas
figur illustr actual vs jmp estim rang revenu metric along select
bpshealthcar spec bpslife bpsappli steril bpstotal mln annual bpsgross bpsup bp y/i impact favor price divestitur larg off-set impact currenc chang invest outsourc reprocessingsg includ bpsoper incom ex bpsup bp y/ytax bpslower expect due stock base compens expens quarternet incom ex mix cc organ y/i consum servic capit equip capit equip backlog increas mln segment oper incom mln due mln spend impact divestitur neg impact currenc fluctuat mix y/i report basi currenc neutral organ growth oper incom segment mln due invest outsourc reprocess mix currenc neutral organ growth quarter capit equip segment consum servic revenu segment oper incom mln due primarili volum favor product mix organ currenc neutral basi primarili due increas volum core medic deivc custom segment oper profit increas mln y/i due primarili revenu growth ri plc
steri corpor develop manufactur market infect prevent contamin control microbi reduct surgic
support product servic healthcar pharmaceut scientif research industri government custom world-wide
movement toward dispos surgic tool decreas need steril med-tech compani bring high-margin
single-us devic marketplac trend obvious reduc need steril surgic procedur
growth driver outsid may take longer expect materi capit spend may take longer rebound expect
tangibl sign capit equip market due rebound meaning delay could impact capit equip
sale estim compani
compani abil gener sustain earn dividend growth depend upon achiev mid-singl digit revenu growth
number factor impact includ limit price pressur macroeconomic-driven chang patient volum
chang capit purchas budget cycl
research analyst prepar report does/do herebi certifi view present report accord my/our
person view secur issuer discuss report mandat sec regul ac part my/our compens
directli indirectli relat specif view recommend express herein certif made
oblig set forth sec regul ac person entiti may use purpos certif made
base my/our analysi date report public i/w assum oblig updat certif reflect fact
circumst event may subsequ come my/our attent sign david turkali daniel stauder
